Drug Profile
LeukoVAX
Latest Information Update: 11 Dec 2003
Price :
$50
*
At a glance
- Originator Inflammatics (CEASED)
- Class Antirheumatics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 28 Aug 2002 Discontinued - Phase-I/II for Rheumatoid arthritis in USA (Injection)
- 04 Feb 1999 Phase-I/II clinical trials for Rheumatoid arthritis in USA (Injection)